Physician profile

Aaron C Smith

Urology · Iowa City, IA

NPI 1871614149

$1,233.48

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$831.10
Food and Beverage$183.75

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Axonics, INC. $976.78 2023 Bulkamid, Axonics
Dornier Medtech America, INC $66.67 2020
Pfizer INC. $64.58 2019-2021
Intuitive Surgical, INC. $38.07 2024
Teleflex LLC $25.51 2021
Bayer Healthcare Pharmaceuticals INC. $19.71 2019
Coloplast Corp $17.26 2020
Abbvie INC. $13.02 2022
Allergan, INC. $11.88 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Aaron C Smith

$1,233.48

in general payments reported 2019-2025

Years
2019-2024
Top company
Axonics, INC.

https://glasscript.com/doctor/1242178/aaron-c-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.